Long-term follow-up of treated and untreated hyperprolactinaemic patients

References

• Archer D. F., Harger J. H., Moore E. E., Hough L. J. Validity of hypothalamic-pituitary testing in hyperprolactinemia: prolactin responses to insulin hypoglycemia and arginine. American Journal of Obstetrics and Gynecology 1981; 141: 556–561
   PubMedGoogle Scholar
• Archer D. F., Lattanzi D. R., Moore E. E., Harger J. H., Herbert D. L. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas. American Journal of Obstetrics and Gynecology 1982; 143: 620–625
   PubMed Web of Science ®Google Scholar
• Bergh T., Nillius S. J., Larsson S. G., Wide L. Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours. Acta Endocrinologica (Copenhagen) 1981; 98: 333–338
   PubMedGoogle Scholar
• Boyar R. M., Kapen S., Finkelstein J. W., Perlow M., Sassin D. F., Fukushima D. K., Weitzman E. D., Hellman L. Hypothalamic-pituitary function in diverse hyperprolactinaemic states. Journal of Clinical Investigation 1974; 53: 1588–1598
   PubMed Web of Science ®Google Scholar
• Boyd A. E., Reichlin S., Turksoy R. N. Galactorrhea-amenorrhea syndrome: diagnosis and therapy. Annals of Internal Medicine 1977; 87: 165–175
   PubMed Web of Science ®Google Scholar
• Bruneton J. N., Drouillard J. P., Sabatier J. C., Elie J. P., Tavernier J. F. Normal variants of the sella tursica. Comparison of plain radiographs and tomograms in 200 cases. Radiology 1979; 131: 99–104
   PubMed Web of Science ®Google Scholar
• Burrow G. N., Wortzman G., Rewcastle N. B., Holgate R. C., Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. New England Journal of Medicine 1981; 304: 156–158
   PubMed Web of Science ®Google Scholar
• Burry K. A., Schiller H. S., Mills R., Harris B., Heinrichs L. Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor. Obstetrics and Gynecology 1978; 52: 19S–22S
   PubMed Web of Science ®Google Scholar
• Campagnoli C., Belforte L., Massara F., Peris C., Molinatti G. M. Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy. Journal of Endocrinologic Investigation 1981; 4: 85–91
   PubMed Web of Science ®Google Scholar
• Chang R. J., Keye W. R., Monroe S. E., Jaffe R. B. Prolactin secreting pituitary adenomas in women. IV. Pituitary function in amenorrhea associated with normal or abnormal serum prolactin and sella polytomography. Journal of Clinical Endocrinology and Metabolism 1980; 51: 830–835
   PubMedGoogle Scholar
• Cowden E. A., Thomson J. A., Doyle D., Ratcliffe J. G., MacPherson P., Teasdale G. M. Tests of prolactin secretion in diagnosis of prolactinomas. Lancet 1979; i: 1155–1158
   Google Scholar
• Crosignani P. G., Ferrari C., Scircduelli C., Picciotti M. C., Caldara R., Malinverni A. Spontaneous and induced pregnancies in hyperprolactinemic women. Obstetrics and Gynecology 1981; 58: 708–713
   PubMed Web of Science ®Google Scholar
• De Schryver A., Vandekerckhove D., Debruyne G. Prolactin-secreting pituitary adenoma. Observations in irradiated patients. Acta Radiologica: Oncology, Radiation Therapy, Physics and Biology 1980; 19: 169–175
   PubMedGoogle Scholar
• Diem K., Lentner C. Scientific Tables, seventh edition. Ciba-Geigy, Basle 1972; 711
   Google Scholar
• Dubois P. J., Orr D. P., Hoy R. J., Herbert D. L., Heinz E. R. Normal sellar variations in frontal tomograms. Radiology 1979; 131: 107–110
   Google Scholar
• Eversmann T., Fahlbusch R., Rjosk H. K., von Werder K. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas. Acta Endocrinologica (Copenhagen) 1979; 92: 413–427
   PubMedGoogle Scholar
• Geehr R. B., Allen W. E., Rothman S. L. G., Spencer D. D. Pluridirectional tomography in the evaluation of pituitary tumors. American Journal of Róntgenology 1978; 130: 105–109
   PubMedGoogle Scholar
• Gemzell C., Wang C. F. Outcome of pregnancy in women with pituitary adenoma. Fertility and Sterility 1979; 31: 363–372
   PubMed Web of Science ®Google Scholar
• Genazzani A. R., Camanni F., Massara F., Picciolini E., Cocchi D., Belforte L., Muller E. E. A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test. Acta Endocrinologica (Copenhagen) 1980; 93: 139–148
   PubMedGoogle Scholar
• Hardy J., Beauregard H., Robert F. Prolactin-secreting pituitary adenomas: transsphenoidal microsurgical treatment. Progress in Prolactin Physiology and Pathology: proceedings of the international symposium on prolactin held in Nice, France, 20–23 October, 1977, C. Robyn, M. Harter. Elsevier/North Holland Biomedical Press, Amsterdam, New York 1978
   Google Scholar
• Healy D. L., Pepperell R. D., Stockdale J., Bremner W. J., Burger H. G. Pituitary autonomy in hyperprolactinemic secondary amenorrhoea: results of hypothalamic-pituitary testing. Journal of Clinical Endocrinology and Metabolism 1977; 44: 809–819
   PubMedGoogle Scholar
• Kelly W. F., Doyle F. H., Mashiter K., Banks L. M., Gordon H., Joplin G. F. Pregnancies in women with hyperprolactinaemia: clinical course and obstetric complications of 41 pregnancies in 27 women. British Journal of Obstetrics and Gynaecology 1979; 86: 698–705
   PubMedGoogle Scholar
• Kletzky O. A., Marrs R. P., Davajan V. Management of patients with hyperprolactinemia and normal or abnormal tomograms. American Journal of Obstetrics and-Gynecology 1983; 147: 528–532
   PubMedGoogle Scholar
• Klijn J. G. M., Lamberts S. W. J., De Jong F. H., Birkenhager J. C. The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors. Fertility and Sterility 1981; 35: 155–161
   PubMedGoogle Scholar
• Kopelman P. G., Pilkington T. R. E., White N., Jeffcoate S. L. Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet 1979; i: 747–749
   Google Scholar
• Lamberts S. W. J., Klijn J. G. M., de Lange S. A., Singh R., Stefanko S. Z., Birkenhäger J. C. The incidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors. Fertility and Sterility 1979; 31: 614–619
   PubMed Web of Science ®Google Scholar
• L'Hermite M., Robyn C. Prolactine hypophysaire humaine: dktection radioimmunologi-que et taux au cours de la grossesse. Annales d'Endocrinologie 1972; 33: 357–360
   PubMedGoogle Scholar
• MacLachlan M. S. F., Banna M. Observer variation in interpreting radiographs of the pituitary fossa. Investigative Radiology 1979; 14: 22–26
   Google Scholar
• March C. M., Kletzky O. A., Davajan V., Teal J., Weiss M., Apuzzo M. L. J., Marrs R. P., Mishell D. R., Jr. Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. American Journal of Obstetrics and Gynecology 1981; 139: 835–844
   PubMed Web of Science ®Google Scholar
• Monroe S. E., Levine L., Chang R. J., Keye W. R., Jr, Yamamoto M., Jaffe R. B. Prolactin-secreting pituitary adenomas. V. Increased gonadotroph responsivity in hyperprolactinemic women with pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1981; 52: 1171–1178
   PubMedGoogle Scholar
• Muhr C., Bergstrom K., Enoksson P., Hugosson R., Lundberg P. O. Follow-up study with computerized tomography and clinical evaluation 5 to 10 years after surgery for pituitary adenoma. Journal of Neurosurgery 1980; 53: 144–148
   PubMedGoogle Scholar
• Noel G. L., Suh H. K., Stone J. G., Frantz A. G. Human prolactin and growth hormone release during surgery and other conditions of stress. Journal of Clinical Endocrinology and Metabolism 1972; 35: 840–851
   PubMed Web of Science ®Google Scholar
• Rjosk H. K., Fahlbusch R., von Werder K. Influence of pregnancies on prolactinomas. Acta Endocrinologica (Copenhagen) 1982a; 100: 332–346
   Google Scholar
• Rjosk H. K., Fahlbusch R., von Werder K. Spontaneous development of hyperprolactinaemia. Acta Endocrinologica (Copenhagen) 1982b; 100: 337–336
   PubMedGoogle Scholar
• Robertson H. J., Rose A., Ehmi B., England J., Meriweather R. Trends in the radiological study of pituitary adenoma. Neuroradiology 1981; 21: 75–78
   PubMedGoogle Scholar
• Serri O., Rasio E., Beauregard H., Hardy J., Somma M. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. New England Journal of Medicine 1983; 309: 280–283
   PubMed Web of Science ®Google Scholar
• Spaak R. F., Baker R., Bienfang D. C., Bergland R. Bromocriptine reduces pituitary tumor size and hypersecretion. Requiem for pituitary surgery. Journal of the American Medical Association 1982; 247: 311–316
   Google Scholar
• Spellacy W. N., Cantor B., Kalra P. S., Buhi W. C., Birk S. A. The effect of varying prolactin levels on pituitary luteinizing hormone and follicle-stimulating hormone response to gonadotropin-releasing hormone. American Journal of Obstetrics and Gynecology 1978; 132: 157–164
   PubMedGoogle Scholar
• Vezina J. L., Sutton T. J. Prolactin-secreting pituitary microadenomas. Roentgenologic diagnosis. American Journal of Roentgenology 1974; 120: 46–54
   Web of Science ®Google Scholar
• Webb C. B., Thominet J. L., Barowsky H., Berelowitz M., Frohman L. A. Evidence for lacto-troph dopamine resistance in idiopathic hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism 1983; 56: 1089–1093
   PubMedGoogle Scholar
• Wolpert S. M., Post K. D., Biller B. J., Molitch M. E. The value of computed tomography in evaluating patients with prolactinomas. Radiology 1979; 131: 117–119
   PubMedGoogle Scholar
• Yen S. S. C. Studies bf the role of dopamine in the control of prolactin and gonadotrophin secretion in humans. Central Regulation of the Endocrine System, K. Fuxe, T. Hökfelt, R. Luft. Plenum Press, New York 1979; 387–416
   Google Scholar